Your browser doesn't support javascript.
loading
A comprehensive review of therapeutic approaches available for the treatment of cholera.
Sousa, Francisca B M; Nolêto, Isabela R S G; Chaves, Leticia S; Pacheco, Gabriella; Oliveira, Ana P; Fonseca, Mikhail M V; Medeiros, Jand V R.
Affiliation
  • Sousa FBM; Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (Lafidg), Post-graduation Program in Biotechnology, Federal University of Parnaíba Delta, Parnaíba, Brazil.
  • Nolêto IRSG; Northeast Biotechnology Network (RENORBIO), Federal University of Piauí, Teresina, Brazil.
  • Chaves LS; Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (Lafidg), Post-graduation Program in Biotechnology, Federal University of Parnaíba Delta, Parnaíba, Brazil.
  • Pacheco G; Northeast Biotechnology Network (RENORBIO), Federal University of Piauí, Teresina, Brazil.
  • Oliveira AP; Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (Lafidg), Post-graduation Program in Biotechnology, Federal University of Parnaíba Delta, Parnaíba, Brazil.
  • Fonseca MMV; Post-graduation Program in Biomedical Sciences, Federal University of Piauí, Parnaíba, Brazil.
  • Medeiros JVR; Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (Lafidg), Post-graduation Program in Biotechnology, Federal University of Parnaíba Delta, Parnaíba, Brazil.
J Pharm Pharmacol ; 72(12): 1715-1731, 2020 Dec.
Article in En | MEDLINE | ID: mdl-32737883
OBJECTIVES: The oral rehydration solution is the most efficient method to treat cholera; however, it does not interfere in the action mechanism of the main virulence factor produced by Vibrio cholerae, the cholera toxin (CT), and this disease still stands out as a problem for human health worldwide. This review aimed to describe therapeutic alternatives available in the literature, especially those related to the search for molecules acting upon the physiopathology of cholera. KEY FINDINGS: New molecules have offered a protection effect against diarrhoea induced by CT or even by infection from V. cholerae. The receptor regulator cystic fibrosis channel transmembrane (CFTR), monosialoganglioside (GM1), enkephalinase, AMP-activated protein kinase (AMPK), inhibitors of expression of virulence factors and activators of ADP-ribosylarginine hydrolase are the main therapeutic targets studied. Many of these molecules or extracts still present unclear action mechanisms. CONCLUSIONS: Knowing therapeutic alternatives and their molecular mechanisms for the treatment of cholera could guide us to develop a new drug that could be used in combination with the rehydration solution.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vibrio cholerae / Cholera / Anti-Bacterial Agents Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: J Pharm Pharmacol Year: 2020 Document type: Article Affiliation country: Brazil Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vibrio cholerae / Cholera / Anti-Bacterial Agents Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: J Pharm Pharmacol Year: 2020 Document type: Article Affiliation country: Brazil Country of publication: United kingdom